March 21, 2015
Below are current clinical trials.2 studies in Aphasia
(open studies only).
Filter this list of studies by location, status and more.
This study is designed to learn more about the use of a new imaging agent AV-1451 which shows strong binding to abmormal tau in the brain, to see if it will allow positron emission tomography (PET) scanning of tau in the brains of patients with Primary Progressive Aphasia.
Jacksonville, Fla., Rochester, Minn.
Frontotemporal Lobar Degeneration (FTLD) is the neuropathological term for a collection of rare neurodegenerative diseases that correspond to four main overlapping clinical syndromes: frontotemporal dementia (FTD), primary progressive aphasia (PPA), corticobasal degeneration syndrome (CBS) and progressive supranuclear palsy syndrome (PSPS). The goal of this study is to build a FTLD clinical research consortium to support the development of FTLD therapies for new clinical trials. The consortium, referred to as Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL), will be headquartered at UCSF and will partner with six patient advocacy groups to manage the consortium. Participants will be evaluated at 14 clinical sites throughout North America and a genetics core will genotype all individuals for FTLD associated genes.
- Clark DG. Approach to the patient with aphasia. http://www.uptodate.com/home. Accessed Feb. 25, 2015.
- Aphasia. The Merck Manual Professional Edition. http://www.merckmanuals.com/professional/neurologic_disorders/function_and_dysfunction_of_the_cerebral_lobes/aphasia.html#v1034169. Accessed Feb. 25, 2015.
- Clark DG. Aphasia: Prognosis and treatment. http://www.uptodate.com/home. Accessed Feb. 25, 2015.
- Aphasia. American Speech-Language-Hearing Association. http://www.asha.org/public/speech/disorders/Aphasia.htm. Accessed Feb. 25, 2015.
- Aphasia. National Institute on Deafness and Other Communication Disorders. http://www.nidcd.nih.gov/health/voice/Pages/aphasia.aspx. Accessed Feb. 26, 2015.